Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

Go back to Resources

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Trends in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Go back to Resources

Trends in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Go back to Resources

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Cord Blood Transplantation (COBLT) Study: An internet data system for the COBLT Study Cord Blood Banks

Go back to Resources

The Cord Blood Transplantation (COBLT) Study: An internet data system for the COBLT Study Cord Blood Banks

Authors:

Location:

Go back to Resources

The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity

Go back to Resources

The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity

Authors:

Location:

Go back to Resources

The Banff 97 working classification of renal allograft pathology

Go back to Resources

The Banff 97 working classification of renal allograft pathology

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The 1997 annual report of the North American Pediatric Transplant Cooperative Study (NAPRTCS)

Go back to Resources

The 1997 annual report of the North American Pediatric Transplant Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines

Go back to Resources

T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and gp120 prime-boost vaccines

Authors:

Location:

Go back to Resources

Steady improvements in short-term graft survival of pediatric renal transplants: The North American Pediatric Transplant Cooperative Study (NAPRTCS) experience

Go back to Resources

Steady improvements in short-term graft survival of pediatric renal transplants: The North American Pediatric Transplant Cooperative Study (NAPRTCS) experience

Authors:

Secondary:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • Current page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification